The effectiveness of clove oil as a topical anesthetic in reducing pain during needle insertion

ISRCTN ISRCTN10078508
DOI https://doi.org/10.1186/ISRCTN10078508
Secondary identifying numbers Funder No. 501100020595
Submission date
18/10/2023
Registration date
18/10/2023
Last edited
10/11/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Dental procedures can be distressing for children, often attributed to the pain experienced during an inferior alveolar nerve block (IANB), a common local anesthesia technique. This study endeavors to address this issue by comparing the efficacy of two analgesic agents: clove oil and 20% benzocaine gel.

Clove oil, derived from the clove plant, has shown promise as a natural analgesic with potential benefits in dentistry. Benzocaine gel, a synthetic local anesthetic, is a conventional choice for pain management during IANB. However, the comparative effectiveness of these two agents in pediatric patients remains largely unexplored.

Who can participate?
Children aged 7-11 years requiring non-urgent dental treatment under IANB.

What does the study involve?
Children were divided into two groups, with an equal number of kids in each group. This study was "double-blind," meaning that both the doctors and the statistician didn't know which group each child belonged to.

In the first group (called the control group), a 20% benzocaine gel was used, while the second group received clove oil. Before applying these substances, the area where the injection would happen was dried. Then, 0.3 mL of each pain-relief product was applied using a cotton roll, and it stayed there for 3 minutes.

A pediatric dentist administered the inferior alveolar nerve block (IANB), which was recorded on a mobile device (Mi 9, Xiaomi) to measure how much pain the participant was feeling by looking at the facial expressions.

What are the possible benefits and risks of participating?
Possible benefits are: Performing non-urgent dental treatment in the mandibular arch such as, pulpotomy, serial extraction, and pulpectomy.
Possible risk is: IANB will be painful if the topical anesthetic is not effective.

Where is the study run from?
Damascus University (Syria)

When is the study starting and how long is it expected to run for?
March 2022 to October 2022

Who is funding the study?
Damascus University (Syria)

Who is the main contact?
Dr Mawia Karkoutly, Mawiamaherkarkoutly@hotmail.com

Contact information

Dr Mawia Karkoutly
Public, Scientific, Principal Investigator

Mazzeh Highway
Damascus
-
Syria

ORCiD logoORCID ID 0000-0003-0227-1560
Phone +963 992647528
Email mawia95.karkoutly@damascusuniversity.edu.sy

Study information

Study designDouble‐blind randomized parallel‐group active-controlled trial
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Dental clinic
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleThe effectiveness of clove oil as a topical anesthetic for healthy children during inferior alveolar nerve block: a randomized controlled trial
Study objectivesThe null hypothesis was that no statistically significant difference would be noted in efficacy of clove oil and benzocaine 20% gel in reducing pain from needle stick in children during the inferior alveolar nerve block.
Ethics approval(s)

Approved 09/05/2022, Ethical and Scientific Committee of Damascus University (Damascus University, Mazzeh Highway, Damascus, -, Syria; +963 992647528; dean.dent@damascusuniversity.edu.sy), ref: N1770

Health condition(s) or problem(s) studiedDental pain
InterventionChildren were randomly assigned into two groups in a ratio 1:1 using simple randomization method. The same number of children were randomly allocated to each intervention arm using randomization online software: https://www.randomizer.org. This was a double-blind trial where clinicians and statistician were blinded to which interventional arms children are assigned to.

20% benzocaine gel was applied for the first group (control group), and clove oil was applied for the second group. Mucosa drying was applied at the site of injection before application of the tested material, then 0,3 mL of each topical anesthetic was applied using a cotton roll for 3 minutes. IANB was performed by one pediatric dentist, and the child was videotaped using a mobile device (Mi 9, Xiaomi). The injection was made more posteriorly and slightly lower since the mandibular foramen is situated at a level lower in the pediatric patient. Therefore, the barrel of dental carpule syringe (Dental carpule syringe, Dental Laboratorio) was directed on the plane between the two primary molars on the opposite site of the arch, then a 27-gauge x 21 mm needle (Disposable Dental Needle, Shanghai Dochem Industries Co., Ltd.) was inserted, and 1.8 mL of 2% lidocaine with epinephrine 1:80,000 (2% Lidocaine HCL Injection, Huons Co., Ltd, Seongnam) was injected.
Intervention typeDrug
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)20% benzocaine gel, clove oil, 2% lidocaine with epinephrine 1:80,000
Primary outcome measure1. The sound, eyes, and motor (SEM) scale was used to measure pain objectively during injection, and it evaluated by a blinded outcome assessor using the recorded video.
2. The Wong–Baker Faces Pain Rating Scale (WBFPS) was used to subjectively assess pain since children were asked to select the face that represented their pain level immediately after the IANB administration.
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date09/03/2022
Completion date20/10/2022

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit7 Years
Upper age limit11 Years
SexBoth
Target number of participants60
Key inclusion criteria1. Healthy children.
2. Children aged 7-11 years.
3. Children with no previous dental experience.
4. Children requiring non-urgent dental treatment under IANB.
Key exclusion criteria1. Children are allergic to any anesthetic agent used in this study.
2. Children with fascial space infections and/or dental abscesses.
3. Special health care needs children.
4. Children have odontophobia.
Date of first enrolment20/06/2022
Date of final enrolment20/10/2022

Locations

Countries of recruitment

  • Syria

Study participating centre

Damascus University
Mazzeh Highway
Damascus
-
Syria

Sponsor information

Damascus University
University/education

Mazzeh Highway
Damascus
-
Syria

Phone +963 992647528
Email info@damascusuniversity.edu.sy
Website http://www.damascusuniversity.edu.sy
ROR logo "ROR" https://ror.org/03m098d13

Funders

Funder type

University/education

Damascus University
Government organisation / Universities (academic only)
Alternative name(s)
University of Damascus, جَامِعَةُ دِمَشْقَ, DU
Location
Syria

Results and Publications

Intention to publish date31/12/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Mawiamaherkarkoutly@hotmail.com

Editorial Notes

10/11/2023: Internal review.
18/10/2023: Trial's existence confirmed by Damascus University.